stella
Alzheimer's DiseaseMarch 2025Summary reviewed September 2026

Monthly Nurse Calls Cut ER Visits and Hospitalizations in Half for Dementia Patients

Families caring for loved ones with moderate to severe dementia got monthly phone calls from a nurse or social worker for two years. The calls focused on managing difficult symptoms, planning ahead, and connecting families to hospice when needed. Patients in the program had half as many emergency room visits and hospitalizations compared to those getting usual care.

What the trial was testing

The IN-PEACE enrolled 402 patients with alzheimer's disease. The study was sponsored by Indiana University and tracked outcomes across the full group of patients who matched the trial's eligibility profile.

Researchers followed patients through treatment and into recovery, tracking the outcomes that mattered most for the disease being studied.

What the results showed

Patients getting monthly support calls had half as many ER visits and hospitalizations over two years.

JAMA · 2025 · NCT03773757

These findings — that patients with dementia got monthly nurse support calls instead of usual care — were published in the JAMA and represent the headline result of the study.

Researchers tracked outcomes across 402 patients enrolled in the trial. The result was consistent enough across the group that the team felt confident reporting it.

What this means for patients

For patients with alzheimer's disease, this result changes the calculus on what to ask their care team about. Whether it changes day-to-day care depends on factors like disease subtype, prior treatments, and where the patient is in their care journey.

What you can do now

If you're caring for someone with moderate or severe dementia at home, this study suggests that regular phone support from a nurse or social worker could help you avoid crisis trips to the hospital. The program didn't reduce dementia symptoms themselves, but it did cut emergency visits in half — likely by helping caregivers manage problems before they became emergencies. Ask your doctor if your health system offers similar dementia care management programs.

Eligibility for the treatments mentioned above depends on specific test results and clinical history. Bring this summary, the trial name, and your most recent labs or pathology report to your next visit.

Open alzheimer's disease trials

RecruitingInterventional study

The Swedish BioFINDER 2 Study

The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is used e.g. to characterize the role of beta-amyloid pathology in early diagnosis of Alzheimer's disease (AD) using amyloid-PET (18F-Flutemetamol) and Aβ analysis in cerebrospinal fluid samples. The BioFINDER 1 study has resulted in more than 40 publications during the last three years, many in high impact journals, and some the of the results have already had important implications for the diagnostic work-up patients with AD in the clinical routine practice. The original BioFINDER 1 cohort started to include participants in 2008. Since then there has been a rapid development of biochemical and neuroimaging technologies which enable novel ways to the study biological processes involved in Alzheimer's disease in living people. There has also been a growing interest in the earliest stages of AD and other neurodegenerative diseases. With the advent of new tau-PET tracers there is now an opportunity to elucidate the role of tau pathology in the pathogenesis of AD and other tauopathies. The Swedish BioFINDER 2 study has been designed to complement the BioFINDER 1 study and to e.g. address issues regarding the role of tau pathology in different dementias and in preclinical stages of different dementia diseases. Further, the clinical assessments and MRI methods have been further optimized compared to BioFINDER 1. Detailed assessments of motor aspects and dual task performance, which is part of a sub-study named Motor-ACT: "Motor aspects and activities in relation to cognitive decline and brain pathologies, has been added to further optimize assessment of motor function.

Ängelholm, Sweden +1 more
RecruitingInterventional study

Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairment

The goal of this randomised clinical trial is to investigate the effectiveness of an innovative therapeutic exercise program emphasizing in dual-task exercises in people with amnestic Mild Cognitive Impairment. The main questions it aims to answer are: Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition? Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise). Participants will: * Perform the exercise program twice a week for three months. * Will be assessed before and after the intervention. * Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.

Pátrai, Greece